Tetrindole

Tetrindole was a drug candidate that functions by reversibly inhibiting monoamine oxidase A; it was first synthesized in Moscow in the early 1990s.^[1] Tetrindole is similar in its chemical structure to pirlindole (Pyrazidol), and metralindole.^[2]

Tetrindole

Clinical data
ATC code	None
Identifiers
IUPAC name 2,3,3a,4,5,6-Hexahydro-8-cyclohexyl-1H-pyrazino[3,2,1-j,k]carbazole
CAS Number	170964-67-7 N[PubChem]
PubChem CID	160020
ChemSpider	140675 Y
UNII	978VSV87L6
ChEBI	CHEBI:77799 N
ChEMBL	ChEMBL4303571
Chemical and physical data
Formula	C20H26N2
Molar mass	294.442 g·mol−1
3D model (JSmol)	Interactive image
SMILES C1CCC(CC1)C2=CC3=C(C=C2)N4CCNC5C4=C3CCC5
InChI InChI=1S/C20H26N2/c1-2-5-14(6-3-1)15-9-10-19-17(13-15)16-7-4-8-18-20(16)22(19)12-11-21-18/h9-10,13-14,18,21H,1-8,11-12H2 Y Key:AUXCHYJDVJZEPG-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

See also

• List of Russian drugs